ERBB2 and neoplasm: Many patients had rather extensive locoregional disease, with nearly 50% of them having cT3-4 tumours and 75% having clinical involvement of axillary lymph nodes, 66% of patients had ER and/or PR-positive disease, 20% HER2-positive disease and 25% triple-negative disease [1].